l 365031 has been researched along with cholecystokinin in 2 studies
| Studies (l 365031) | Trials (l 365031) | Recent Studies (post-2010) (l 365031) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 10,914 | 466 | 1,074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, MG; Chang, RS; Chen, R; Chen, TB; Freidinger, RM; Lotti, VJ; Rosegay, A | 1 |
| Dourish, CT; Hendrie, CA; Neill, JC; Shepherd, JK | 1 |
2 other study(ies) available for l 365031 and cholecystokinin
| Article | Year |
|---|---|
Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
Topics: Animals; Benzodiazepinones; Binding, Competitive; Brain; Cholecystokinin; Guinea Pigs; Kinetics; Male; Organ Specificity; Pancreas; Parietal Cells, Gastric; Rats; Receptors, Cholecystokinin | 1989 |
The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Mice, Inbred DBA; Phenylurea Compounds; Receptors, Cholecystokinin | 1993 |